National Oncology Institute Receives Rare ESMO Designation for Cancer Care
PANAMA CITY, July 25, 2026 – Panama’s Instituto Oncologico Nacional received an ESMO Designated Centre recognition, placing the public hospital in a select group of Latin American institutions recognized for integrated oncology and palliative care.
Telemetro reported that the institute is the first public hospital in Central America and the third institution in Latin America to obtain the designation. The recognition is connected to the European Society for Medical Oncology’s program for cancer centers that combine treatment with palliative-care standards.
For patients, the designation matters because cancer care is not limited to surgery, chemotherapy or radiotherapy. Pain control, emotional support, family guidance and end-of-life planning can be just as central to quality of life.
The milestone also raises expectations. A formal international recognition can strengthen institutional pride, but it also increases public attention on waiting times, medicines, referrals and the everyday experience of patients seeking treatment.
This is one of the strongest verified health stories in Panama this week because it combines national achievement with a deeply personal issue for thousands of families.
Why it matters
Cancer care affects families across the country, and international recognition can support trust, standards and future investment.
What happens next
The institute will need to maintain the standards behind the designation while continuing to respond to demand for timely treatment.
